State University. All subjects (1) used a Cochlear Corporation signal processor, (2) had at least 24 months of experience with electric stimulation, (3) had at least 20 years of experience with amplification prior to implantation, and (4) were known, from previous testing, to have bimodal benefit. No patient had residual hearing in the operated ear. Biographical data are presented in table 1 . All were paid in hourly wage for their participation. The audiogram for each patient's nonimplanted ear is shown in figure 1 .
Signal Processing
Signal processing was implemented on a personal digital assistant (PDA)-based signal processor [Ali et al., 2011 [Ali et al., , 2013 . This cell-phone-sized research device functions as the external signal processor for a CI. The device was used in an 'offline' mode only, i.e. speech signals were processed offline based on each patient's mapping parameters, stimulation parameters for electric stimulation were computed using the ACE algorithm, and the resulting parameters were passed directly to the internal receiver. Direct S1  70 familial  28  28  2  74  58  S2  54 unknown 24  39  10  52  46  S3  74 unknown 22  28  6  66  12  S4  76 noise  56  56  4  72  6  S5  37 unknown 37  37  4  72  36 Duration of significant hearing loss was calculated from the time patients started to have difficulty using the telephone. CNC = Single-word (consonant-nucleus-consonant) recognition; HA = hearing aid; S = subject. 236 stimulation removed the need for a sound booth or a quiet room and loudspeakers to deliver speech signals to the patient.
The PDA also functioned as a hearing aid and synchronously provided (1) parameters for electrical stimulation and (2) an acoustic signal to the contralateral ear, delivered via an insert receiver, processed in the manner of a hearing aid. To accommodate the degree of hearing loss for each patient, acoustic signals were amplified and subjected to the frequency-gain characteristic prescribed by the National Acoustic Laboratories (NAL-RP) prescription method [Byrne and Dillon, 1986; Byrne et al., 1990] using MATLAB.
The threshold-equalizing noise test [Moore et al., 2000 [Moore et al., , 2004 and a fast method for measuring psychophysical tuning curves [Sęk and Moore, 2011] were used to detect the presence of dead regions along the cochlea with residual acoustic hearing. This information was used to further shape the amplification prescribed by the NAL-RP formula, i.e. amplification was not provided at and above a dead region. All processing was done offline in MATLAB. For subject (S)1, S2, S3, S4 and S5, cochlear dead regions started at edge frequencies of 1,500, 1,000, 1,500, 4,000 and 750 Hz, respectively, and extended upwards from the edge frequencies.
Stimuli
The speech stimuli were sentences from the AzBio sentence test lists [Spahr et al., 2012] . The noise signal was the multitalker babble from Spahr et al. [2012] .
Procedures
The overall logic of the experiment was as follows: (1) present the electric signal in sufficient noise to drive performance near 60% correct and then (2) add (to the electric signal) the acoustic signal at levels ranging from just above the detection threshold to above the level of the CI signal.
To accomplish this goal, for each patient the following steps were implemented, using sentences from the AzBio sentence test corpus as test material: (1) Determine the most comfortable presentation level for the CI signal, using the Advanced Bionics loudness scale (see below) and an ascending/descending method of stimulus presentation, and then determine a signal-to-noise ratio that drives CIalone performance to near 60% correct; the signal level was fixed and the noise level was decreased to achieve the desired signal-to-noise ratio (2) Find the signal levels that range from just noticeable (level 1) to the upper limit of loudness (level 9) for signals delivered to the nonimplanted ear, using an 11-discrete-point loudness scale (Advanced Bionics loudness scale, where 0 = off, 1 = just noticeable, 2 = very soft, 3 = soft, 4 = comfortable but too soft, 5 = comfortable but soft, 6 = most comfortable, 7 = loud but comfortable, 8 = loud, 9 = upper loudness limit, and 10 = too loud) (3) Find, using an ascending/descending procedure, the most comfortable level (6 on the Advanced Bionics loudness scale) for signals directed to the nonimplanted ear (with implant switched off) (4) Find the 'balance point' for electric and acoustic stimulation by varying the level of the acoustic signal relative to the CI signal; this was achieved using a picture of a head with an arc in front of it and asking the subject to indicate when the acoustic and electric stimulation produced the sensation that the stimulus was balanced directly in front of the head. For some patients this procedure was easier than judgments of relative loudness, although both procedures likely accessed the same underlying perceptual information. The signals were repeated using an ascending/descending method until the patient reported the signals were balanced (5) Find the level of the acoustic signal that was (i) just noticeably softer than the CI (the auditory image shifted towards the CI side of the head) and (ii) just noticeably louder than the CI (the auditory image shifted towards the hearing-aid side of the head); this was accomplished by changing the level of the acoustic stimulus in 1-dB steps until the patient indicated it was either softer than or louder than the CI stimulus (or until the two types of stimulation were 'unbalanced') The speech stimuli used for determining the loudness levels described above were AzBio sentences that were not used in the following speech recognition tests. The procedure of determining loudness levels was repeated until 2-3 consistent results were achieved.
To create the acoustic signals for the experiment, the dynamic range of acoustic hearing, i.e. the decibel range in acoustic stimulation from the lower to the upper limit (as determined in No. 2 above), was divided into 7 steps. The first step was 'just noticeable' stimulation and the last step was equal to or less than the 'upper limit of loudness'. An additional acoustic signal was created at the level judged to be 'most comfortable loudness' (see No. 3 above). The acoustic signals were combined with the CI signal to produce 8 test conditions. Twenty AzBio sentences were presented in each test condition. The order of conditions was fixedfrom softest acoustic signal plus CI to loudest acoustic signal plus CI. There were 5 practice trials of AzBio sentences before each test condition.
Results
The results for each patient are shown in figure 1 . In each figure, the level of performance with the implant alone is indicated by a dotted line and labeled 'E-alone'. We succeeded in driving performance to near 60% correct for S3, 4 and 5 by adding noise (using signal-to-noise ratios of +7 dB, +13 dB and +2 dB, respectively). S1 and 2 were tested in quiet -noise was not necessary to reach our criterion.
All patients benefited from acoustic stimulation -the mean was 29 percentage points [minimum = 13 percentage points (S3); maximum = 49 percentage points (S2)]. Benefit was an inverted U function, with minimum or no improvement at the lowest level of acoustic stimulation (with one exception), the most improvement near the balance or the acoustic maximum comfortable loudness level (MCL) point, and a lower level of performance at the highest levels of acoustic stimulation.
In figure 1 the gray boxes indicate the range of acoustic stimulus levels for signals reported to be 'just softer' than the CI stimulus (the left edge of the box) and 'just louder' than the CI stimulus (the right edge of the box). Box width was for S1 = 7 dB, for S2 = 30 dB, for S3 = 12 dB , for S4 = 6 dB and for S5 = 11 dB.
The point of balance between the electric and the acoustic stimulus is indicated by the upward-pointing triangle at the bottom of each box. The MCL point for the acoustic stimulus alone is indicated by the downwardpointing triangle at the top of the box. The balance and MCL points were within, on average, 2.6 dB (S1 = 2 dB; S2 = 0 dB; S3 = 3 dB; S4 = 5 dB; S5 = 3 dB).
Performance in the condition that produced the best performance overall was little different than performance in the condition in which the acoustic signal was presented at MCL. The mean difference between the two conditions was -4.2 percentage points (S1 = -10 percentage points; S2 = -1 percentage point; S3 = -2 percentage points; S4 = -3 percentage points; S5 = -5 percentage points). Although all difference scores are in the same direction, none of the difference scores exceed the expected variance of the AzBio test material [Spahr et al., 2012] .
Discussion
Our aim in this project was to determine, for bimodal CI patients, how performance varies as a function of the difference in level between the CI signal and the acoustic signal. We find that the benefit of adding the low-frequency signal to the CI signal is an inverted Ushaped function of the level of the acoustic signal. Very soft acoustic signals (as expected) produce very little benefit: the first data point in each figure is near the level of performance with the CI alone (with one exception -see discussion below). Signals presented near the balance point between acoustic and electric stimulation always provided the highest levels of performance. And, for all subjects, performance fell for acoustic signals that were judged to be much higher in level than the CI stimulus. This decrease in performance could be due to a shift in attention to the loudest signal and away from the CI signal, or due to central masking of the electric signal by the acoustic signal [van Hoesel and Clark, 1997; James et al., 2001] . Our data do not speak to these possibilities.
Inspection of figure 1 suggests that for 3 of the 5 subjects (S1, S4 and S5) an acoustic stimulus that is judged slightly softer, or slightly unbalanced towards the CI ear, provides the most benefit when added to the CI signal.
Thus, a clinical recommendation for setting the acoustic signal in balance with, or slightly softer than, the CI signal is supported by the data. Moreover, the data suggest that balance does not need to be determined with a high degree of precision.
Acoustic signals set to MCL, without reference to the CI signal, also support high levels of benefit. When the acoustic signals were set to MCL, scores, on average, were within 4 percentage points of the best score. Thus, balancing is not necessary to achieve a high level of benefit from the acoustic signal. This could be a useful datum for setting the level of the auditory signal for patients who have difficulty understanding CI versus acoustic signal balancing procedures.
For all subjects, some signals labeled as softer than the CI signal provided benefit to intelligibility. This suggests that patients who cannot achieve normal loudness growth may still benefit from acoustic stimulation. For S2, even the acoustic signal labeled as 'just detectable' provided a very substantial gain in intelligibility. We have no account for this but note that this patient also had an extremely large range when judging signals to be just softer than or just louder than the CI stimulus. This patient might have had difficulty judging loudness. It is also the case that this was one of two listeners for whom noise was not necessary to depress performance to our target range. It is possible that the absence of noise facilitated the access to the information in the low-level acoustic signal.
Conclusion
The data suggest that (1) acoustic signals perceived as significantly softer than a CI signal can contribute to speech understanding in the bimodal condition, (2) acoustic signals that are slightly softer than, or balanced with, a CI signal provide the largest benefit to speech understanding, and (3) acoustic signals presented at MCL provide nearly as much benefit as signals that have been balanced with a CI signal. Studies involving a larger number of patients and other kinds of test materials are necessary to assess the generality of these results.
